The Research and Development team at Xeris Pharmaceuticals focuses on innovating and advancing the development of patient-friendly injectable formulations, specifically targeting conditions such as diabetes, epilepsy, and immunology. This multidisciplinary team collaborates on analytical development, formulation strategies, and nonclinical research to ensure the efficacy, safety, and quality of new products, driving the company's commitment to enhancing patient care through groundbreaking therapies.
Gabriela Toomer
Manager Nonclinical Research A...
John Thottathil
Vice President Of Product Deve...
Joseph Traunfeld
Scientist Ii, Analytical Devel...
Nathan A. Sieracki
Senior Manager, CMC
Paige Whelpley
Scientist I, Analytical Develo...
Peter Valentinsson
Senior Vice President, Product...
Wendy Hu
Scientist Ii, Formulation Deve...
View all